Heterogeneity in tumor chromatin-doxorubicin binding revealed by in vivo fluorescence lifetime imaging confocal endomicroscopy

Abstract We present an approach to quantify drug–target engagement using in vivo fluorescence endomicroscopy, validated with in vitro measurements. Doxorubicin binding to chromatin changes the fluorescence lifetime of histone-GFP fusions that we measure in vivo at single-cell resolution using a conf...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hugh Sparks, Hiroshi Kondo, Steven Hooper, Ian Munro, Gordon T. Kennedy, Christopher Dunsby, Paul M. W. French, Erik Sahai
Formato: Artigo
Lenguaje:inglés
Publicado: 2018
Acceso en línea:https://doi.org/10.1038/s41467-018-04820-6
https://www.nature.com/articles/s41467-018-04820-6.pdf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!